Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Staghorn69on Aug 11, 2017 11:08pm
213 Views
Post# 26573724

RE:Again, Again and Again

RE:Again, Again and AgainI feel money is the problem, then the initial China Deal better get
closed ASAP, and the only thing that will save that steaming pile of sh it is the resulting CHINA PHARMA DEAL that of course you can't do in China without first greasing the business
community with the first sweetheart "deal" (A. Which I don't believe for a moment, and B. Which makes me question why a legit company would even bother, which C. Begs the question if PLI is even a legit company..).   So some can be saved if the China Deal closes AND PL announces the subsequent 4050 Chinese Pharma deal for say $75 MIL FOR 25% - $150Mil for 50%....  now why anyone would pay more than the initial $25 Mil is beyond me, the bar has been set but this is me dreaming.  THAT kind of series of deals would take the $ pressure off.  Now PL and Fred, time to put all your hype BS talk into action and try to execute...  Fail and our next financing will be a sucker deal at 90 cents.
Bullboard Posts